Actively Recruiting

Age: 18Years +
All Genders
NCT06600568

Novel Therapeutic Approach for Human T-cell Malignancies

Led by Istituto Oncologico Veneto IRCCS · Updated on 2025-12-08

120

Participants Needed

2

Research Sites

104 weeks

Total Duration

On this page

Sponsors

I

Istituto Oncologico Veneto IRCCS

Lead Sponsor

I

Istituto Nazionale Tumori IRCSS-Fondazione G.Pascale

Collaborating Sponsor

AI-Summary

What this Trial Is About

This multicenter translational study, with prospective and retrospective samples, aims to identify new strategies to selectively eliminate neoplastic T cells by modulating intracellular ROS levels. Interactions between drugs capable of activating the apoptotic process (e.g., Venetoclax) and drugs capable of altering ROS homeostasis (e.g., inhibitors of the enzyme glucose-6-phosphate dehydrogenase) will be examined. The most promising compounds will be selected based on results obtained in vitro on cell lines and PDX already available in the laboratory, and then will be assayed ex vivo in cells obtained from patients with resistant/refractory T-cell neoplasms.

CONDITIONS

Official Title

Novel Therapeutic Approach for Human T-cell Malignancies

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with pre- and post-thymic T-cell leukemia/lymphoma
  • Patients of both sexes
  • Age of patients older than 18 years
  • Patient is willing to provide written and signed informed consent for participation in the study
Not Eligible

You will not qualify if you...

  • Serious illness or medical condition that does not allow the patient to be managed according to standard treatment protocols, including uncontrolled active infection.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Istituto Nazionale Tumori Fondazione G.Pascale

Naples, Italy, 80100

Actively Recruiting

2

Istituto Oncologico Veneto

Padova, Italy, 35128

Actively Recruiting

Loading map...

Research Team

M

Michele Gottardi, MD

CONTACT

G

GianLuca De Salvo, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here